Log in

NASDAQ:PRANPrana Biotechnology Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.58
0.00 (0.00 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.58
Now: $0.58
$0.60
50-Day Range
$0.95
MA: $1.41
$2.06
52-Week Range
$1.09
Now: $0.58
$2.91
Volume137,709 shs
Average Volume130,956 shs
Market Capitalization$5.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment for Parkinson's disease and other movement disorders; and PBT2, which has completed four Phase I studies and a Phase IIa clinical trial for patients with Alzheimer's disease. It also completed the IMAGINE Phase II biomarker imaging trial in Alzheimer's disease; and a open label IMAGINE Extension study and the Reach2HD Phase IIa trial in Huntington disease. The company was founded in 1997 and is based in Melbourne, Australia.
Read More
Prana Biotechnology logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRAN
CUSIPN/A
Phone61-3-9349-4906

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150,000.00
Book Value$1.40 per share

Profitability

Miscellaneous

Employees14
Market Cap$5.16 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PRAN News and Ratings via Email

Sign-up to receive the latest news and ratings for PRAN and its competitors with MarketBeat's FREE daily newsletter.

Prana Biotechnology (NASDAQ:PRAN) Frequently Asked Questions

Has Prana Biotechnology been receiving favorable news coverage?

News stories about PRAN stock have been trending neutral on Saturday, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Prana Biotechnology earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave media coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutPrana Biotechnology.

Who are some of Prana Biotechnology's key competitors?

What other stocks do shareholders of Prana Biotechnology own?

Who are Prana Biotechnology's key executives?

Prana Biotechnology's management team includes the following people:
  • Mr. Geoffrey Paul Kempler, Co-Founder, Exec. Chairman, CEO & MD (Age 64)
  • Ms. Kathryn Andrews, Chief Financial Officer (Age 52)
  • Dr. David A. Stamler, Chief Medical Officer, Sr. VP of Clinical Devel. and Member of R&D Advisory Board (Age 58)
  • Prof. Rudolph Emile Tanzi, Chief Scientific Advisor and Member of R&D Advisory Board
  • Dr. Steven D. Targum M.D., Chief Medical Advisor

What is Prana Biotechnology's stock symbol?

Prana Biotechnology trades on the NASDAQ under the ticker symbol "PRAN."

What is Prana Biotechnology's stock price today?

One share of PRAN stock can currently be purchased for approximately $0.58.

How big of a company is Prana Biotechnology?

Prana Biotechnology has a market capitalization of $5.16 million and generates $150,000.00 in revenue each year. The biotechnology company earns $-6,400,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Prana Biotechnology employs 14 workers across the globe.

What is Prana Biotechnology's official website?

The official website for Prana Biotechnology is www.pranabio.com.

How can I contact Prana Biotechnology?

Prana Biotechnology's mailing address is Level 3 460 Bourke Street, Melbourne C3, 3000. The biotechnology company can be reached via phone at 61-3-9349-4906 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.